|
1.Chow,J.Y.,Ma,L.,Zhu,M.,Cho,C., H.The potentiating actions of cigarette smoking on ethanol-induced gastric mucosal damage in rats. Gastroenterology, 1997. 113(4): p.1188-97. 2.Chan,F.K.,Helicobacter pylori, NSAIDs and gastrointestinal haemorrhage. Eur J Gastroenterol Hepatol, 2002. 14(1): p.1-3. 3.Leung,A.M.,M.J.Redlak,and T.A. Miller,Aspirin-induced mucosal cell death in human gastric cells: role of a caspase-independent mechanism. Dig Dis Sci, 2009. 54(1): p. 28-35. 4.Nair,S.,Norkus,E.P.Hertan, H. Pitchumoni, C. S., Micronutrient antioxidants in gastric mucosa and serum in patients with gastritis and gastric ulcer: does Helicobacter pylori infection affect the mucosal levels? J Clin Gastroenterol,2000. 30(4): p.381-5. 5.Naito,Y.,Yoshikawa, T.Iinuma, S. Yagi, N.et al., Rebamipide protects against indomethacin-induced gastric mucosal injury in healthy volunteers in a double-blind, placebo-controlled study. Dig Dis Sci, 1998. 43(9 Suppl): p.83S-89S. 6.Amann,R.and B.A. Peskar,Anti-inflammatory effects of aspirin and sodium salicylate. Eur J Pharmacol, 2002. 447(1): p.1-9. 7.Laine,L.,Approaches to nonsteroidal anti-inflammatory drug use in the high-risk patient. Gastroenterology, 2001. 120(3): p.594-606. 8.Meade,E.A.,W.L.Smith, and D.L.DeWitt, Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs. J Biol Chem, 1993. 268(9): p.6610-4. 9.Gudis, K.and C.Sakamoto,The role of cyclooxygenase in gastric mucosal protection. Dig Dis Sci, 2005. 50 Suppl 1: p.S16-23. 10.Chandrasekharan, N.V.,Dai, H., Roos,K. L.,Evanson, N. K. et al., COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression. Proc Natl Acad Sci U S A, 2002. 99(21): p.13926-31. 11.Tanaka,A.,Araki,H.,Komoike,Y.,et al.,Inhibition of both COX-1 and COX-2 is required for development of gastric damage in response to nonsteroidal antiinflammatory drugs. J Physiol Paris,2001.95(1-6): p.21-7. 12.Ivey,K.J.,Mechanisms of nonsteroidal anti-inflammatory drug-induced gastric damage. Actions of therapeutic agents. Am J Med,1988. 84(2A): p.41-8. 13.Aibe,T.,Fuji,T.,Okita,K.,et al.,A fundamental study of normal layer structure of the gastrointestinal wall visualized by endoscopic ultrasonography. Scand J Gastroenterol Suppl, 1986. 123: p. 6-15. 14.Yakabi,K.and T.Nakamura, Acute gastroduodenal mucosal lesion. Nippon Rinsho,1998.56(9): p.2336-42. 15.Wallace,J.L.and D.N. Granger, The cellular and molecular basis of gastric mucosal defense. Faseb J, 1996. 10(7): p. 731-40. 16.Hirose,H.,K.Takeuchi,and S.Okabe, Effect of indomethacin on gastric mucosal blood flow around acetic acid-induced gastric ulcers in rats. Gastroenterology, 1991. 100(5 Pt 1): p.1259-65. 17.Whittle,B.J.,Thirteenth Gaddum Memorial Lecture. Neuronal and endothelium-derived mediators in the modulation of the gastric microcirculation: integrity in the balance. Br J Pharmacol,1993.110(1): p.3-17. 18.Yoshikawa,T.and M. Kondo, Free radicals in digestive diseases.Nippon Ronen Igakkai Zasshi,1990. 27(2): p. 155-60. 19.Werz,O.,D.Szellas,and D.Steinhilber, Reactive oxygen species released from granulocytes stimulate 5-lipoxygenase activity in a B-lymphocytic cell line. Eur J Biochem, 2000. 267(5): p.1263-9. 20.Huang,C.K.,Zhan,L,Hannigan,M.O.,et al.,P47(phox)-deficient NADPH oxidase defect in neutrophils of diabetic mouse strains, C57BL/6J-m db/db and db/+. J Leukoc Biol, 2000.67(2):p.210-5. 21.Shen,Y.C.,Chiou,W.F.,Chou,Y.C.,et al.,Mechanisms in mediating the anti-inflammatory effects of baicalin and baicalein in human leukocytes.Eur J Pharmacol, 2003. 465(1-2): p.171-81. 22.Dinauer,M.C.,Disorders of neutrophil function: an overview. Methods Mol Biol, 2007. 412: p. 489-504. 23.Watanabe,T.,Arakawa,T.,Tominaga,K.,et al., Neutrophil accumulation in development gastric ulcer induced by submucosal injection of endothelin-1 in rats. Dig Dis Sci, 2000. 45(5): p.880-8. 24.Chattopadhyay,I.,Bandyopadhyay,U.,Biswas,K.,et al., Indomethacin inactivates gastric peroxidase to induce reactive-oxygen-mediated gastric mucosal injury and curcumin protects it by preventing peroxidase inactivation and scavenging reactive oxygen. Free Radic Biol Med, 2006. 40(8): p.1397-408. 25.Podoprigorova,V.G.,Khibin,L.S.,Kozlov,N.B.,et al., Effectiveness of synthetic antioxidants in treatment of patients with peptic ulcer (an open randomized controlled trial).Klin Med (Mosk),1999.77(3): p.32-5. 26.Galecka,E.,Mrowicka,M.,Malinowska, K.,et al., Chosen non-enzymatic substances that participate in a protection against overproduction of free radicals. Pol Merkur Lekarski, 2008.25(147): p.269-72. 27.Cadenas,E.and H. Sies,The lag phase. Free Radic Res, 1998.28(6): p.601-9. 28.Kwiecien,S.,Pawlik,M.W.,Sliwowski,Z.,et al., Involvement of sensory afferent fibers and lipid peroxidation in the pathogenesis of stress-induced gastric mucosa damage. J Physiol Pharmacol,2007.58 Suppl 3: p.149-62. 29.Valko,M.,Leibfritz, D.,Moncol, J.,et al., Free radicals and antioxidants in normal physiological functions and human disease.Int J Biochem Cell Biol,2007. 39(1): p. 44-84. 30.Hirokawa,K.and H.Kawasaki, Changes in glutathione in gastric mucosa of gastric ulcer patients. Res Commun Mol Pathol Pharmacol,1995.88(2): p.163-76. 31.Van Iersel, M.L.H. Verhagen, and P.J.van Bladeren, The role of biotransformation in dietary (anti)carcinogenesis. Mutat Res,1999. 443(1-2): p.259-70. 32.Hayes,J.D.and D.J.Pulford, The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance.Crit Rev Biochem Mol Biol, 1995. 30(6): p.445-600. 33.Wang,C.,Bammler,T.K.,Guo,Y.,et al.,Mu-class GSTs are responsible for aflatoxin B(1)-8,9-epoxide-conjugating activity in the nonhuman primate macaca fascicularis liver. Toxicol Sci, 2000. 56(1): p.26-36. 34.Awasthi,S.,Srivastava,S.K.,Ahmad, F.,et al., Interactions of glutathione S-transferase-pi with ethacrynic acid and its glutathione conjugate. Biochim Biophys Acta, 1993. 1164(2): p.173-8. 35.Anttila,S.,Hirvonen,A.,Vainio, H.,et al., Immunohistochemical localization of glutathione S transferases in human lung. Cancer Res,1993. 53(23): p. 5643-8. 36.Wang,G.Z.,Yin,G. L.,Zhou,G.,et al., Aspirin can elicit the recurrence of gastric ulcer induced with acetic acid in rats. Cell Physiol Biochem, 2007.20(1-4): p.205-12. 37.Steer,K.A., Wallace, T. M.,Bolton, C. H.,et al., Aspirin protects low density lipoprotein from oxidative modification. Heart,1997. 77(4): p.333-7. 38.Patrono,C.,Garcia Rodriguez, L.A.,Landolfi,R.,et al., Low-dose aspirin for the prevention of atherothrombosis. N Engl J Med,2005.353(22): p.2373-83. 39.Fiorucci,S.,de Lima,O.M.,Jr.,Mencarelli, A.,et al., Cyclooxygenase-2-derived lipoxin A4 increases gastric resistance to aspirin-induced damage. Gastroenterology, 2002. 123(5): p.1598-606. 40.Fiorucci,S.,Distrutti,E.,de Lima,O. M.,et al., Relative contribution of acetylated cyclo-oxygenase (COX)-2 and 5-lipooxygenase (LOX) in regulating gastric mucosal integrity and adaptation to aspirin. Faseb J, 2003. 17(9): p. 1171-3. 41.D''Argenio,G.,Mazzone,G.,Tuccillo,C.,et al.,Apple polyphenol extracts prevent aspirin-induced damage to the rat gastric mucosa. Br J Nutr, 2008. 100(6): p.1228-36. 42.Chan, F.K.,Ching,J.Y.,Hung,L. C.,et al.,Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding. N Engl J Med, 2005. 352(3): p.238-44. 43.Scarpignato,C.and I.Pelosini, Prevention and treatment of non-steroidal anti-inflammatory drug-induced gastro-duodenal damage: rationale for the use of antisecretory compounds. Ital J Gastroenterol Hepatol,1999. 31 Suppl 1: p.S63-72. 44.Yang,Y.X.,Lewis,J.D.,Epstein, S.,et al. Long-term proton pump inhibitor therapy and risk of hip fracture. Jama 2006 ; 2947-53. 45.Laheij,R.J.,Sturkenboom,M.C.,Hassing, R.J.,et al., Risk of community-acquired pneumonia and use of gastric acid- suppressive drugs.Jama,2004.292(16): p.1955-60. 46.Berenguer,B.,Trabadela,C.,Sanchez-Fidalgo,S.,et al., The aerial parts of Guazuma ulmifolia Lam. protect against NSAID-induced gastric lesions. J Ethnopharmacol, 2007. 114(2): p.153-60. 47.Saijo,R.,Murakami,K.,Nohara,T.,et al.,Studies on the constituents of Solanum plants.II. On the constituents of the immature berries of Solanum nigrum L. Yakugaku Zasshi, 1982. 102(3): p.300-5. 48.Sultana,S.,Perwaiz,S.,Iqbal,M.,et al.,Crude extracts of hepatoprotective plants, Solanum nigrum and Cichorium intybus inhibit free radical-mediated DNA damage. J Ethnopharmacol,1995. 45(3): p.189-92. 49.Lee,S.J.,Ko,J.H.,Lim, K.,et al.,150 kDa glycoprotein isolated from Solanum nigrum Linne enhances activities of detoxicant enzymes and lowers plasmic cholesterol in mouse. Pharmacol Res, 2005. 51(5): p.399-408. 50.Lee,S.J.and K.T.Lim, 150 kDa glycoprotein isolated from Solanum nigrum Linne stimulates caspase-3 activation and reduces inducible nitric oxide production in HCT-116 cells. Toxicol In Vitro, 2006. 20(7): p. 1088-97. 51.Lin,H.M.,Tseng,H.C.,Wang, C. J.,et al., Hepatoprotective effects of Solanum nigrum Linn extract against CCl(4)-induced oxidative damage in rats. Chem Biol Interact, 2008. 171(3): p.283-93. 52.Berenguer,B.,Sanchez,L.M.,Quilez,A.,et al.,Protective and antioxidant effects of Rhizophora mangle L. against NSAID-induced gastric ulcers. J Ethnopharmacol, 2006. 103(2): p.194-200. 53.Thun MJ, Henley SJ, Patrono C: Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues. J Natl Cancer Inst 2002; 94:252- 66. 54. Harris RE, Beebe-Donk J, Doss H, Burr Doss D: Aspirin, ibuprofen, and other non-steroidal anti-inflammatory drugs in cancer prevention: a critical review of non-selective COX-2 blockade (review). Oncol Rep 2005; 13:559-83. 55. Chan AT, Giovann ucc i E L, Meyerhardt J A, Schernhammer ES , Curhan GC , Fuchs CS : Long-term use of aspirin and nonsteroidal anti- inflammatory drugs and risk of colorectal cancer. JAMA 2005; 294:914-23.
|